{
    "Trade/Device Name(s)": [
        "Thyretain TM TSI Reporter BioAssay",
        "TSI Reporter"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K092229",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083391"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZO"
    ],
    "Summary Letter Date": "May 14, 2010",
    "Summary Letter Received Date": "May 17, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5870"
    ],
    "Regulation Name(s)": [
        "Thyroid autoantibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Thyroid stimulating autoantibodies to TSH receptors"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Thyretain TM TSI Reporter BioAssay for qualitative detection of thyroid stimulating autoantibodies in serum as an aid in the differential diagnosis of Graves' disease.",
    "Indications for Use Summary": "Qualitative detection in serum of thyroid stimulating autoantibodies to TSH receptors as an aid in the differential diagnosis of patients with Graves' disease.",
    "fda_folder": "Immunology"
}